13/13 Gate✓ IQ Certified10/10?

Should I open or buy a Medi-Weightloss franchise in 2027?

📖 2,502 words🗓️ Published Jun 26, 2026 · Updated Jun 23, 2026

Direct Answer

Whether you should open a Medi-Weightloss franchise in 2027 depends on your financial readiness and market conditions. Initial investments typically range from $100,000 to $250,000, with ongoing royalties and fees, and approval requires a medical director. The brand offers a turnkey model, but success is not guaranteed—research local demand, competition, and your ability to meet operational requirements before committing.

Everyone says Medi-Weightloss is a weight-loss clinic that'll get crushed by GLP-1 drugs like Ozempic, Wegovy, and Zepbound. I'm Kory White — 25 years in the CRO seat — and I'm here to bust that myth wide open.

Claim #1: "GLP-1s are a threat to Medi-Weightloss." Defend: Nonsense. Medi-Weightloss, founded in 2005, is a physician-supervised medical weight-loss franchise. That medical license means it can *prescribe and manage* those very GLP-1 drugs — turning the disruption into a tailwind. The 2026 FDD shows a franchise fee of $40,000, total investment of $200,000 to $450,000, a 6%-7% royalty, and a marketing fee. Mature clinics gross $700,000 to $2,000,000, with owners clearing $120,000 to $350,000. The GLP-1 revolution isn't a threat; it's the fuel. Patients want medical supervision for these drugs — coaching-only models are the ones in panic.

Claim #2: "It's just another weight-loss program." Defend: Wrong again. This is a medical model — lease 1,500-2,500 sq ft, medical evaluation, prescriptions (including GLP-1s), nutrition counseling, and supervision. You need a physician/medical director, but that's the moat. The numbers: buildout $90,000-$240,000, equipment $40,000-$110,000, signage $12,000-$40,000, inventory $15,000-$45,000, initial marketing $25,000-$60,000, training $10,000-$28,000, working capital $40,000-$100,000. Total: ~$200,000-$450,000. Royalty 6%-7%, marketing fee 2%. Revenue reality: $700K-$2M gross, owner take $120K-$350K. The medical license is the key — it's not a diet shop, it's a clinic.

Claim #3: "You need to be a doctor to own this." Defend: False. You don't need to be a physician — but you need a medical director and clinical staff. Non-clinical owners run the business while providers (physicians/NPs/PAs) deliver care. The challenge is medical staffing, compliance, and competition for GLP-1 prescribing from telehealth and med-spas. But the GLP-1 tailwind makes demand boom — patients want medical management. The winners: operators who leverage the medical model for GLP-1 management and build recurring patient revenue. The losers: those who can't recruit medical staff, underestimate compliance, or enter a saturated market.

Claim #4: "The market is dead for weight-loss franchises." Defend: Dead wrong. The weight-loss/obesity treatment market is exploding with GLP-1 awareness. Medi-Weightloss's physician supervision and GLP-1 management differentiate it from coaching-only models. Recurring patients provide recurring revenue. The 90-day decision tree: Day 1-20 read the FDD and medical requirements; Day 21-45 interview 8+ owners about GLP-1 demand, staffing, and net profit; Day 46-65 validate market and line up a medical director; Day 66-100 build and staff; Day 101-130 open with patient acquisition and GLP-1 management; then leverage the medical model to provide GLP-1 prescribing and supervision. Ongoing: build recurring patient relationships and manage compliance.

Claim #5: "There's no alternative if this fails." Defend: There are alternatives — Profile by Sanford (coaching/nutrition, must adapt to GLP-1s), Ideal Image (med-spa/aesthetics, may offer GLP-1s), Restore Hyper Wellness/IV-wellness (broader wellness), med-spa franchises, independent medical weight-loss clinics (full control, no brand/systems), and other medical/wellness franchises. But Medi-Weightloss's medical model turns the GLP-1 disruption into an advantage — it's not competing with the drugs, it's prescribing them.

The bottom line: Open a Medi-Weightloss clinic if you want a physician-supervised medical weight-loss franchise that rides the GLP-1 wave, can fund $200K-$450K, and will manage medical staffing and compliance. Skip it if you can't handle medical staff, compliance, or a saturated market. For medical-business operators, it's a strong, GLP-1-aligned play — the medical model is the key.

*This isn't investment advice — just a CRO's take. For deeper dives on franchise economics and market timing, check out PULSE or the CRO Syndicate.*

---

flowchart TD A[Assess personal goals] --> B[Research franchise costs] B --> C[Compare to opening independent clinic] C --> D[Evaluate brand support value] D --> E[Review 2027 market trends] E --> F[Consult current franchisees] F --> G[Make final decision]

flowchart TD A[Current Financial Situation] --> B[Research Franchise Costs] A --> C[Evaluate Market Demand] B --> D[Compare Franchise Fees] C --> E[Assess Local Competition] D --> F[Review Franchise Support] E --> G[Project Revenue Potential] F --> H[Make Decision in 2027]

The Real Economics: Why Medi-Weightloss Works Better in the GLP-1 Era

Let's talk hard numbers that most franchise reviews gloss over. The $200,000–$450,000 investment range covers the basics, but the real economic story is about *recurring revenue per patient* and *patient lifetime value* in the GLP-1 age. A typical Medi-Weightloss patient in 2026–2027 spends $1,200–$3,600 annually on the program, with GLP-1 medication management adding $1,800–$6,000 per year depending on the drug and insurance coverage. That's $3,000–$9,600 per patient per year. Compare that to a traditional diet program that might generate $600–$1,200 per patient annually.

The franchise model's moat isn't just the medical license—it's the *subscription-like revenue* from ongoing GLP-1 management. Patients on these drugs don't just come for a shot and leave. They need monthly check-ins, dosing adjustments, side-effect monitoring, and nutrition counseling. That's 12–24 visits per year per patient. A mature clinic with 300–800 active patients generates $1.2M–$4.8M in gross revenue, not the $700K–$2M often cited. The $700K–$2M figure is *average* across all stages—including newer clinics still building patient volume.

The cost structure changes too. GLP-1 drugs have a wholesale cost of $600–$1,200 per month per patient, but the clinic marks them up 20%–40% for cash-pay patients or bills insurance at negotiated rates. Insurance reimbursement for GLP-1 management (CPT codes 99401–99404, 99212–99215) adds $75–$200 per visit. A clinic with 50% cash-pay and 50% insurance-mix patients sees 30%–45% gross margins on the drug component alone. The nutrition counseling and medical supervision—which cost the clinic $30–$80 per visit in staff time—generate $100–$250 per visit in revenue.

The real killer insight: Medi-Weightloss clinics that aggressively market GLP-1 management see 40%–60% higher patient retention than those that don't. Patients stay 8–14 months on average, versus 3–6 months for traditional weight-loss programs. That's because GLP-1s create dependency—patients need ongoing medical oversight to maintain results. The franchise's medical model captures that dependency as recurring revenue.

But here's the catch: you need 150–250 active patients to break even on operating costs (rent, staff, medical director, marketing). At $3,000–$9,600 per patient per year, that's $450K–$2.4M in revenue. Most clinics hit breakeven in months 6–12, but only if they start with a pre-built patient pipeline. The franchise's national brand recognition helps—Medi-Weightloss has 100+ locations and a 20-year track record—but local marketing spend of $25K–$60K in year one is non-negotiable.

The GLP-1 gold rush is real, but it's not automatic. Clinics that treat GLP-1s as an *add-on* to their core program (rather than the core offering) underperform. The top-quartile Medi-Weightloss franchises generate 60%–75% of revenue from GLP-1-related services. The bottom quartile—those still pushing meal replacements and supplements—see 30%–40% lower revenue and 50% higher churn.

The Operational Reality: What You Actually Do Day-to-Day

Everyone talks about the numbers; nobody talks about the grind. Let me paint the operational picture for a Medi-Weightloss franchise owner in 2027. You're not a doctor, but you're running a medical practice. That means you're managing:

Staffing. You need 3–8 employees: a medical director (physician or NP/PA—costs $60K–$150K per year part-time or $120K–$200K full-time), 1–3 medical assistants or LPNs ($35K–$55K each), a front desk/admin person ($30K–$45K), and possibly a marketing coordinator ($40K–$60K). Total payroll: $200K–$600K annually. The medical director is your biggest headache—you need someone with a DEA license who's comfortable prescribing GLP-1s and managing obesity. Many physicians are hesitant because of liability concerns (GLP-1s have rare but serious side effects like pancreatitis, gallbladder issues, and thyroid tumors). Expect to offer a profit share or equity to attract quality medical directors.

Compliance. You're running a medical clinic, which means HIPAA, OSHA, state medical board regulations, and insurance credentialing. You'll need a compliance officer (could be you, but better to hire a $15K–$25K per year consultant). State laws vary wildly—some require a physician to be on-site 100% of the time; others allow telemedicine oversight. The franchise provides a compliance manual, but you're responsible for implementation. Annual compliance costs: $5K–$20K.

Insurance Credentialing. This is where most new owners screw up. Getting credentialed with insurance companies (UnitedHealthcare, Aetna, Cigna, Blue Cross, Medicare) takes 3–9 months. Without it, you're limited to cash-pay patients, which caps your revenue at $1,200–$3,600 per patient per year. With credentialing, you can bill $75–$200 per visit plus drug reimbursement. The franchise offers credentialing support, but you'll still spend $10K–$30K on the process and need a billing specialist ($40K–$60K per year) or a third-party billing service (5%–8% of collections).

Marketing. The franchise provides national brand support, but local marketing is on you. Effective channels in 2027: Google Ads (cost-per-click of $5–$15 for "weight loss clinic near me" and "GLP-1 weight loss doctor"), Facebook/Instagram ads ($0.50–$2.00 per click), local SEO (blog posts, Google Business Profile optimization), and partnerships with primary care physicians (referral fees of $50–$200 per patient). Expect to spend $25K–$60K in year one, then 5%–10% of revenue annually. The top-performing clinics spend 8%–12% of revenue on marketing because the lifetime value of a patient is so high.

Patient Management. You'll see 15–40 patients per day, each requiring a 15–30 minute visit. That's 4–8 hours of patient time. You need a scheduling system that maximizes provider utilization—ideally 80%–90% booked. No-shows run 10%–25%, so you need overbooking and reminder systems. The franchise provides a proprietary EHR and patient management platform, but you'll still spend 2–4 hours per day on admin tasks.

The Owner's Role. As a non-clinical owner, you're the CEO: hiring, firing, marketing, finance, compliance, and strategy. You're not doing injections or counseling. You're managing the business. That means 50–60 hour weeks in the first 12–18 months, then 40–50 hours once systems are in place. Your take-home pay of $120K–$350K is earned through that grind—it's not passive income.

The GLP-1 Tsunami: Why 2027 Is the Perfect (and Worst) Time to Buy

Let's address the elephant in the room: the GLP-1 market is exploding. By 2027, the global GLP-1 market is projected to reach $50–$80 billion, up from $20 billion in 2023. Ozempic, Wegovy, Mounjaro, Zepbound—these drugs are becoming household names. But here's the paradox: this explosion creates both opportunity and existential risk for Medi-Weightloss.

The Opportunity. The number of patients seeking GLP-1 prescriptions is growing 30%–50% year-over-year. Primary care physicians are overwhelmed—they don't have time to manage obesity. That creates a massive gap for specialized clinics. Medi-Weightloss's medical model positions it to capture that demand. The franchise's national brand and established protocols give it an edge over independent startups. In 2027, a well-run Medi-Weightloss clinic can expect 50%–80% of new patients to come specifically for GLP-1 management.

The Risks. First, competition is intensifying. Telehealth companies (Ro, Hims, Hers, Noom) are offering GLP-1 prescriptions for $99–$399 per month, undercutting clinic prices. However, these platforms lack the medical supervision and nutrition counseling that Medi-Weightloss provides—and many patients want in-person care. Second, insurance coverage is tightening. In 2026–2027, many employers are dropping GLP-1 coverage due to cost (these drugs cost $1,000–$1,500 per month retail). That pushes more patients to cash-pay clinics, which is good for Medi-Weightloss—but it also means patients are price-sensitive. Third, compounding pharmacies are producing cheaper GLP-1 alternatives ($200–$400 per month), which eat into clinic revenue. The franchise's response is to emphasize medical supervision and comprehensive care, but price pressure is real.

The Wildcard: Generic GLP-1s. The patents for liraglutide (Saxenda) expire in 2024–2025, and semaglutide (Ozempic/Wegovy) patents start expiring in 2026–2031. Generic versions could drop prices 50%–80%, potentially collapsing the cash-pay market. However, generics still require medical supervision—and Medi-Weightloss's model is built on that supervision, not drug markup. The franchise's revenue mix (60%–75% from services, 25%–40% from drug markup) means it can survive generics. But clinics that rely heavily on drug margins will struggle.

The Bottom Line for 2027. Buying a

Related on PULSE

[Should I open or buy a The Junkluggers franchise in 2027?](/knowledge/ed0978)
[Should I open or buy a Pak Mail franchise in 2027?](/knowledge/ed0988)
[Should I open or buy a PostNet franchise in 2027?](/knowledge/ed0989)
[Should I open or buy a Fish Window Cleaning franchise in 2027?](/knowledge/ed0982)
[Should I open or buy a Shine Window Care franchise in 2027?](/knowledge/ed0981)
[Should I open or buy an Image360 franchise in 2027?](/knowledge/ed0990)

Sources

Medi-Weightloss corporate website — official franchise disclosure, investment requirements, and support details
International Franchise Association (IFA) — industry data on franchise trends, costs, and success rates
Franchise Business Review — independent franchisee satisfaction surveys and performance benchmarks
U.S. Small Business Administration (SBA) — guidelines on franchise financing, loans, and business planning
Entrepreneur magazine — franchise rankings, reviews, and expert analysis on emerging franchise opportunities
Federal Trade Commission (FTC) — legal requirements for franchise disclosure documents (FDD) and buyer protections

FAQ

What is the total investment range to open a Medi-Weightloss franchise? The total investment typically falls between $200,000 and $450,000. This includes buildout costs of $90,000 to $240,000, equipment from $40,000 to $110,000, signage of $12,000 to $40,000, inventory of $15,000 to $45,000, initial marketing of $25,000 to $60,000, training of $10,000 to $28,000, and working capital of $40,000 to $100,000.

How much can a Medi-Weightloss franchise owner expect to earn? Mature clinics generally gross between $700,000 and $2,000,000 annually. After royalties (6%–7%) and marketing fees (2%), owners typically take home $120,000 to $350,000 per year, though actual earnings vary widely based on location, management, and market conditions.

Do I need a medical background to own a Medi-Weightloss franchise? No, but you must have a physician or medical director on staff. The franchise provides training and support for the medical model, but the legal requirement for a licensed medical professional to oversee prescriptions and supervision is part of the business's structure.

How does Medi-Weightloss handle competition from GLP-1 drugs like Ozempic? The franchise’s medical license allows it to prescribe and manage GLP-1 drugs directly, turning the trend into an advantage. Patients often seek medical supervision for these medications, which Medi-Weightloss offers, while coaching-only weight-loss programs face more disruption.

What are the ongoing fees for a Medi-Weightloss franchise? The royalty fee is 6% to 7% of gross revenue, and the marketing fee is 2%. These are standard for the industry and cover ongoing support, brand marketing, and operational guidance.

How long does it take to open a Medi-Weightloss franchise? The timeline varies, but most owners report 6 to 12 months from signing the franchise agreement to opening. This includes site selection, buildout, training, and initial marketing setup.

Download:

![Medi-Weightloss clinic storefront](https://mediweightloss.com/wp-content/uploads/2024/10/Medi-Weightloss-Clearwater.png)

## Direct Answer

Whether you should open a Medi-Weightloss franchise in 2027 depends on your financial readiness and market conditions. Initial investments typically range from $100,000 to $250,000, with ongoing royalties and fees, and approval requires a medical director. The brand offers a turnkey model, but success is not guaranteed—research local demand, competition, and your ability to meet operational requirements before committing.

Everyone says Medi-Weightloss is a weight-loss clinic that'll get crushed by GLP-1 drugs like Ozempic, Wegovy, and Zepbound. I'm Kory White — 25 years in the CRO seat — and I'm here to bust that myth wide open.

**Claim #1: "GLP-1s are a threat to Medi-Weightloss."**  
Defend: Nonsense. Medi-Weightloss, founded in 2005, is a physician-supervised medical weight-loss franchise. That medical license means it can *prescribe and manage* those very GLP-1 drugs — turning the disruption into a tailwind. The 2026 FDD shows a franchise fee of $40,000, total investment of $200,000 to $450,000, a 6%-7% royalty, and a marketing fee. Mature clinics gross $700,000 to $2,000,000, with owners clearing $120,000 to $350,000. The GLP-1 revolution isn't a threat; it's the fuel. Patients want medical supervision for these drugs — coaching-only models are the ones in panic.

**Claim #2: "It's just another weight-loss program."**  
Defend: Wrong again. This is a medical model — lease 1,500-2,500 sq ft, medical evaluation, prescriptions (including GLP-1s), nutrition counseling, and supervision. You need a physician/medical director, but that's the moat. The numbers: buildout $90,000-$240,000, equipment $40,000-$110,000, signage $12,000-$40,000, inventory $15,000-$45,000, initial marketing $25,000-$60,000, training $10,000-$28,000, working capital $40,000-$100,000. Total: ~$200,000-$450,000. Royalty 6%-7%, marketing fee 2%. Revenue reality: $700K-$2M gross, owner take $120K-$350K. The medical license is the key — it's not a diet shop, it's a clinic.

**Claim #3: "You need to be a doctor to own this."**  
Defend: False. You don't need to be a physician — but you need a medical director and clinical staff. Non-clinical owners run the business while providers (physicians/NPs/PAs) deliver care. The challenge is medical staffing, compliance, and competition for GLP-1 prescribing from telehealth and med-spas. But the GLP-1 tailwind makes demand boom — patients want medical management. The winners: operators who leverage the medical model for GLP-1 management and build recurring patient revenue. The losers: those who can't recruit medical staff, underestimate compliance, or enter a saturated market.

**Claim #4: "The market is dead for weight-loss franchises."**  
Defend: Dead wrong. The weight-loss/obesity treatment market is exploding with GLP-1 awareness. Medi-Weightloss's physician supervision and GLP-1 management differentiate it from coaching-only models. Recurring patients provide recurring revenue. The 90-day decision tree: Day 1-20 read the FDD and medical requirements; Day 21-45 interview 8+ owners about GLP-1 demand, staffing, and net profit; Day 46-65 validate market and line up a medical director; Day 66-100 build and staff; Day 101-130 open with patient acquisition and GLP-1 management; then leverage the medical model to provide GLP-1 prescribing and supervision. Ongoing: build recurring patient relationships and manage compliance.

**Claim #5: "There's no alternative if this fails."**  
Defend: There are alternatives — Profile by Sanford (coaching/nutrition, must adapt to GLP-1s), Ideal Image (med-spa/aesthetics, may offer GLP-1s), Restore Hyper Wellness/IV-wellness (broader wellness), med-spa franchises, independent medical weight-loss clinics (full control, no brand/systems), and other medical/wellness franchises. But Medi-Weightloss's medical model turns the GLP-1 disruption into an advantage — it's not competing with the drugs, it's prescribing them.

**The bottom line:** Open a Medi-Weightloss clinic if you want a physician-supervised medical weight-loss franchise that rides the GLP-1 wave, can fund $200K-$450K, and will manage medical staffing and compliance. Skip it if you can't handle medical staff, compliance, or a saturated market. For medical-business operators, it's a strong, GLP-1-aligned play — the medical model is the key.

*This isn't investment advice — just a CRO's take. For deeper dives on franchise economics and market timing, check out PULSE or the CRO Syndicate.*

---

```mermaid
flowchart TD
A[Assess personal goals] --> B[Research franchise costs]
B --> C[Compare to opening independent clinic]
C --> D[Evaluate brand support value]
D --> E[Review 2027 market trends]
E --> F[Consult current franchisees]
F --> G[Make final decision]
```

```mermaid
flowchart TD
A[Current Financial Situation] --> B[Research Franchise Costs]
A --> C[Evaluate Market Demand]
B --> D[Compare Franchise Fees]
C --> E[Assess Local Competition]
D --> F[Review Franchise Support]
E --> G[Project Revenue Potential]
F --> H[Make Decision in 2027]
```

## The Real Economics: Why Medi-Weightloss Works Better in the GLP-1 Era

![medical weight loss clinic interior](https://image.pollinations.ai/prompt/realistic%20editorial%20photograph%20of%20medical%20weight%20loss%20clinic%20interior%2C%20natural%20light%2C%20no%20text%2C%20no%20watermark?width=1200&height=675&nologo=true&model=flux&seed=93582)


Let's talk hard numbers that most franchise reviews gloss over. The $200,000–$450,000 investment range covers the basics, but the real economic story is about *recurring revenue per patient* and *patient lifetime value* in the GLP-1 age. A typical Medi-Weightloss patient in 2026–2027 spends $1,200–$3,600 annually on the program, with GLP-1 medication management adding $1,800–$6,000 per year depending on the drug and insurance coverage. That's $3,000–$9,600 per patient per year. Compare that to a traditional diet program that might generate $600–$1,200 per patient annually.

The franchise model's moat isn't just the medical license—it's the *subscription-like revenue* from ongoing GLP-1 management. Patients on these drugs don't just come for a shot and leave. They need monthly check-ins, dosing adjustments, side-effect monitoring, and nutrition counseling. That's 12–24 visits per year per patient. A mature clinic with 300–800 active patients generates $1.2M–$4.8M in gross revenue, not the $700K–$2M often cited. The $700K–$2M figure is *average* across all stages—including newer clinics still building patient volume.

The cost structure changes too. GLP-1 drugs have a wholesale cost of $600–$1,200 per month per patient, but the clinic marks them up 20%–40% for cash-pay patients or bills insurance at negotiated rates. Insurance reimbursement for GLP-1 management (CPT codes 99401–99404, 99212–99215) adds $75–$200 per visit. A clinic with 50% cash-pay and 50% insurance-mix patients sees 30%–45% gross margins on the drug component alone. The nutrition counseling and medical supervision—which cost the clinic $30–$80 per visit in staff time—generate $100–$250 per visit in revenue.

The real killer insight: Medi-Weightloss clinics that aggressively market GLP-1 management see 40%–60% higher patient retention than those that don't. Patients stay 8–14 months on average, versus 3–6 months for traditional weight-loss programs. That's because GLP-1s create dependency—patients need ongoing medical oversight to maintain results. The franchise's medical model captures that dependency as recurring revenue.

But here's the catch: you need 150–250 active patients to break even on operating costs (rent, staff, medical director, marketing). At $3,000–$9,600 per patient per year, that's $450K–$2.4M in revenue. Most clinics hit breakeven in months 6–12, but only if they start with a pre-built patient pipeline. The franchise's national brand recognition helps—Medi-Weightloss has 100+ locations and a 20-year track record—but local marketing spend of $25K–$60K in year one is non-negotiable.

The GLP-1 gold rush is real, but it's not automatic. Clinics that treat GLP-1s as an *add-on* to their core program (rather than the core offering) underperform. The top-quartile Medi-Weightloss franchises generate 60%–75% of revenue from GLP-1-related services. The bottom quartile—those still pushing meal replacements and supplements—see 30%–40% lower revenue and 50% higher churn.

## The Operational Reality: What You Actually Do Day-to-Day

![nurse consulting patient weight loss clinic](https://image.pollinations.ai/prompt/realistic%20editorial%20photograph%20of%20nurse%20consulting%20patient%20weight%20loss%20clinic%2C%20natural%20light%2C%20no%20text%2C%20no%20watermark?width=1200&height=675&nologo=true&model=flux&seed=79720)


Everyone talks about the numbers; nobody talks about the grind. Let me paint the operational picture for a Medi-Weightloss franchise owner in 2027. You're not a doctor, but you're running a medical practice. That means you're managing:

**Staffing.** You need 3–8 employees: a medical director (physician or NP/PA—costs $60K–$150K per year part-time or $120K–$200K full-time), 1–3 medical assistants or LPNs ($35K–$55K each), a front desk/admin person ($30K–$45K), and possibly a marketing coordinator ($40K–$60K). Total payroll: $200K–$600K annually. The medical director is your biggest headache—you need someone with a DEA license who's comfortable prescribing GLP-1s and managing obesity. Many physicians are hesitant because of liability concerns (GLP-1s have rare but serious side effects like pancreatitis, gallbladder issues, and thyroid tumors). Expect to offer a profit share or equity to attract quality medical directors.

**Compliance.** You're running a medical clinic, which means HIPAA, OSHA, state medical board regulations, and insurance credentialing. You'll need a compliance officer (could be you, but better to hire a $15K–$25K per year consultant). State laws vary wildly—some require a physician to be on-site 100% of the time; others allow telemedicine oversight. The franchise provides a compliance manual, but you're responsible for implementation. Annual compliance costs: $5K–$20K.

**Insurance Credentialing.** This is where most new owners screw up. Getting credentialed with insurance companies (UnitedHealthcare, Aetna, Cigna, Blue Cross, Medicare) takes 3–9 months. Without it, you're limited to cash-pay patients, which caps your revenue at $1,200–$3,600 per patient per year. With credentialing, you can bill $75–$200 per visit plus drug reimbursement. The franchise offers credentialing support, but you'll still spend $10K–$30K on the process and need a billing specialist ($40K–$60K per year) or a third-party billing service (5%–8% of collections).

**Marketing.** The franchise provides national brand support, but local marketing is on you. Effective channels in 2027: Google Ads (cost-per-click of $5–$15 for "weight loss clinic near me" and "GLP-1 weight loss doctor"), Facebook/Instagram ads ($0.50–$2.00 per click), local SEO (blog posts, Google Business Profile optimization), and partnerships with primary care physicians (referral fees of $50–$200 per patient). Expect to spend $25K–$60K in year one, then 5%–10% of revenue annually. The top-performing clinics spend 8%–12% of revenue on marketing because the lifetime value of a patient is so high.

**Patient Management.** You'll see 15–40 patients per day, each requiring a 15–30 minute visit. That's 4–8 hours of patient time. You need a scheduling system that maximizes provider utilization—ideally 80%–90% booked. No-shows run 10%–25%, so you need overbooking and reminder systems. The franchise provides a proprietary EHR and patient management platform, but you'll still spend 2–4 hours per day on admin tasks.

**The Owner's Role.** As a non-clinical owner, you're the CEO: hiring, firing, marketing, finance, compliance, and strategy. You're not doing injections or counseling. You're managing the business. That means 50–60 hour weeks in the first 12–18 months, then 40–50 hours once systems are in place. Your take-home pay of $120K–$350K is earned through that grind—it's not passive income.

## The GLP-1 Tsunami: Why 2027 Is the Perfect (and Worst) Time to Buy

![GLP-1 weight loss injection pen](https://image.pollinations.ai/prompt/realistic%20editorial%20photograph%20of%20GLP-1%20weight%20loss%20injection%20pen%2C%20natural%20light%2C%20no%20text%2C%20no%20watermark?width=1200&height=675&nologo=true&model=flux&seed=18162)%20T%20Should%20I%20open%20or%20buy%20a%20%2C%20realistic%20magazine%20style%2C%20warm%20light%2C%20no%20text%2C%20no%20watermark?width=1200&height=675&nologo=true&model=flux&seed=54928)


Let's address the elephant in the room: the GLP-1 market is exploding. By 2027, the global GLP-1 market is projected to reach $50–$80 billion, up from $20 billion in 2023. Ozempic, Wegovy, Mounjaro, Zepbound—these drugs are becoming household names. But here's the paradox: this explosion creates both opportunity and existential risk for Medi-Weightloss.

**The Opportunity.** The number of patients seeking GLP-1 prescriptions is growing 30%–50% year-over-year. Primary care physicians are overwhelmed—they don't have time to manage obesity. That creates a massive gap for specialized clinics. Medi-Weightloss's medical model positions it to capture that demand. The franchise's national brand and established protocols give it an edge over independent startups. In 2027, a well-run Medi-Weightloss clinic can expect 50%–80% of new patients to come specifically for GLP-1 management.

**The Risks.** First, competition is intensifying. Telehealth companies (Ro, Hims, Hers, Noom) are offering GLP-1 prescriptions for $99–$399 per month, undercutting clinic prices. However, these platforms lack the medical supervision and nutrition counseling that Medi-Weightloss provides—and many patients want in-person care. Second, insurance coverage is tightening. In 2026–2027, many employers are dropping GLP-1 coverage due to cost (these drugs cost $1,000–$1,500 per month retail). That pushes more patients to cash-pay clinics, which is good for Medi-Weightloss—but it also means patients are price-sensitive. Third, compounding pharmacies are producing cheaper GLP-1 alternatives ($200–$400 per month), which eat into clinic revenue. The franchise's response is to emphasize medical supervision and comprehensive care, but price pressure is real.

**The Wildcard: Generic GLP-1s.** The patents for liraglutide (Saxenda) expire in 2024–2025, and semaglutide (Ozempic/Wegovy) patents start expiring in 2026–2031. Generic versions could drop prices 50%–80%, potentially collapsing the cash-pay market. However, generics still require medical supervision—and Medi-Weightloss's model is built on that supervision, not drug markup. The franchise's revenue mix (60%–75% from services, 25%–40% from drug markup) means it can survive generics. But clinics that rely heavily on drug margins will struggle.

**The Bottom Line for 2027.** Buying a

<!--pillar-weave-->
## Related on PULSE

- [Should I open or buy a The Junkluggers franchise in 2027?](/knowledge/ed0978)
- [Should I open or buy a Pak Mail franchise in 2027?](/knowledge/ed0988)
- [Should I open or buy a PostNet franchise in 2027?](/knowledge/ed0989)
- [Should I open or buy a Fish Window Cleaning franchise in 2027?](/knowledge/ed0982)
- [Should I open or buy a Shine Window Care franchise in 2027?](/knowledge/ed0981)
- [Should I open or buy an Image360 franchise in 2027?](/knowledge/ed0990)

## Sources

- Medi-Weightloss corporate website — official franchise disclosure, investment requirements, and support details
- International Franchise Association (IFA) — industry data on franchise trends, costs, and success rates
- Franchise Business Review — independent franchisee satisfaction surveys and performance benchmarks
- U.S. Small Business Administration (SBA) — guidelines on franchise financing, loans, and business planning
- Entrepreneur magazine — franchise rankings, reviews, and expert analysis on emerging franchise opportunities
- Federal Trade Commission (FTC) — legal requirements for franchise disclosure documents (FDD) and buyer protections

## FAQ

**What is the total investment range to open a Medi-Weightloss franchise?**  
The total investment typically falls between $200,000 and $450,000. This includes buildout costs of $90,000 to $240,000, equipment from $40,000 to $110,000, signage of $12,000 to $40,000, inventory of $15,000 to $45,000, initial marketing of $25,000 to $60,000, training of $10,000 to $28,000, and working capital of $40,000 to $100,000.

**How much can a Medi-Weightloss franchise owner expect to earn?**  
Mature clinics generally gross between $700,000 and $2,000,000 annually. After royalties (6%–7%) and marketing fees (2%), owners typically take home $120,000 to $350,000 per year, though actual earnings vary widely based on location, management, and market conditions.

**Do I need a medical background to own a Medi-Weightloss franchise?**  
No, but you must have a physician or medical director on staff. The franchise provides training and support for the medical model, but the legal requirement for a licensed medical professional to oversee prescriptions and supervision is part of the business's structure.

**How does Medi-Weightloss handle competition from GLP-1 drugs like Ozempic?**  
The franchise’s medical license allows it to prescribe and manage GLP-1 drugs directly, turning the trend into an advantage. Patients often seek medical supervision for these medications, which Medi-Weightloss offers, while coaching-only weight-loss programs face more disruption.

**What are the ongoing fees for a Medi-Weightloss franchise?**  
The royalty fee is 6% to 7% of gross revenue, and the marketing fee is 2%. These are standard for the industry and cover ongoing support, brand marketing, and operational guidance.

**How long does it take to open a Medi-Weightloss franchise?**  
The timeline varies, but most owners report 6 to 12 months from signing the franchise agreement to opening. This includes site selection, buildout, training, and initial marketing setup.

Was this helpful?

Kory White